"Floridian Clinical Research is a multi-specialty clinical research facility located in South Florida, focused primarily on Phase I through IV clinical trials."

During the past decade, Floridian Clinical Research, LLC conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 7 clinical trials were completed, i.e. on average, 24.1% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 7 clinical trials were completed. i.e. 28% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Floridian Clinical Research, LLC" #1 sponsor was "Gilead Sciences" with 4 trials, followed by "Celgene" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "Madrigal Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Floridian Clinical Research, LLC" #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Parexel" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Floridian Clinical Research, LLC" are "Crohn Disease" (3 trials), "HIV-1-infection" (3 trials), "Hypertension, Portal" (2 trials), "Non-Alcoholic Fatty Liver Disease" (2 trials) and "Nonalcoholic Fatty Liver Disease" (2 trials). Many other conditions were trialed in "Floridian Clinical Research, LLC" in a lesser frequency.

Most popular intervention types in "Floridian Clinical Research, LLC" are "Drug" (25 trials), "Other" (7 trials), "Biological" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Ozanimod" (3 trials), "B/F/TAF" (2 trials), "BI 685509" (2 trials) and "Oral Lenacapavir" (2 trials). Other intervention names were less common.

The vast majority of trials in "Floridian Clinical Research, LLC" are 29 trials for "All" genders.

Currently, there are NaN active trials in "Floridian Clinical Research, LLC". undefined are not yet recruiting, 13 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Floridian Clinical Research, LLC, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Floridian Clinical Research, LLC, 4 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".